<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND AIMS: Endoscopic resection is safe and effective to remove early <z:hpo ids='HP_0002664'>neoplasia</z:hpo> (ie,high-grade intra-epithelial <z:hpo ids='HP_0002664'>neoplasia</z:hpo>/early <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>) in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>To prevent metachronous lesions during follow-up, the remaining <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> can be removed by stepwise radical endoscopic resection (SRER) </plain></SENT>
<SENT sid="2" pm="."><plain>The aim was to evaluate the combined experience in four tertiary referral centres with SRER to eradicate <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> with early <z:hpo ids='HP_0002664'>neoplasia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: DESIGN: Retrospective cohort study </plain></SENT>
<SENT sid="4" pm="."><plain>SETTING: Four tertiary referral centres </plain></SENT>
<SENT sid="5" pm="."><plain>PARTICIPANTS: 169 patients (151 males, age 64 years (IQR 57-71), <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> 3 cm (IQR 2-5)) with early <z:hpo ids='HP_0002664'>neoplasia</z:hpo> in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> &lt; or = 5 cm, without deep submucosal infiltration or <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e>, treated by SRER between January 2000 and September 2006 </plain></SENT>
<SENT sid="6" pm="."><plain>INTERVENTION: Endoscopic resection every 4-8 weeks, until complete endoscopic and histological eradication of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and <z:hpo ids='HP_0002664'>neoplasia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: According to intention-to-treat analysis complete eradication of <z:hpo ids='HP_0000001'>all</z:hpo> <z:hpo ids='HP_0002664'>neoplasia</z:hpo> and <z:hpo ids='HP_0000001'>all</z:hpo> <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> by the end of the treatment phase was reached in 97.6% (165/169) and 85.2% (144/169) of patients, respectively </plain></SENT>
<SENT sid="8" pm="."><plain>One patient had progression of <z:hpo ids='HP_0002664'>neoplasia</z:hpo> during treatment and died of metastasised <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (0.6%) </plain></SENT>
<SENT sid="9" pm="."><plain>After median follow-up of 32 months (IQR 19-49), complete eradication of <z:hpo ids='HP_0002664'>neoplasia</z:hpo> and <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> was sustained in 95.3% (161/169) and 80.5% (136/169) of patients, respectively </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo>, severe complications occurred in 1.2% of patients, and 49.7% of patients developed symptomatic stenosis </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: SRER of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> &lt; or = 5 cm containing early <z:hpo ids='HP_0002664'>neoplasia</z:hpo> appears to be an effective treatment modality with a low rate of recurrent lesions during follow-up </plain></SENT>
<SENT sid="12" pm="."><plain>The procedure, however, is technically demanding and is associated with <z:e sem="disease" ids="C0014866" disease_type="Disease or Syndrome" abbrv="">oesophageal stenosis</z:e> in half of the patients </plain></SENT>
</text></document>